Denali Therapeutics shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $94k | 4.4k | 21.32 |
| 2023-09-30 | $224k | 11k | 20.62 |
| 2023-06-30 | $146k | 4.9k | 29.45 |
| 2023-03-31 | $67k | 2.9k | 22.95 |
| 2022-12-31 | $148k | 5.4k | 27.65 |
| 2022-09-30 | $164k | 5.4k | 30.64 |
| 2022-06-30 | $157k | 5.4k | 29.33 |
| 2021-09-30 | $59k | 1.2k | 49.75 |
| 2021-03-31 | $47k | 833 | 56.42 |
| 2019-12-31 | $18k | 1.1k | 16.78 |